检索结果-南通市图书馆

广西师范学院学报（哲学社会科学版） 2003年第3期24卷 122-126,140页

作者：裘燮君徐州师范大学中文系

寻先生两篇考论《经典释文》“从、邪”、“船、禅”两读切语的论文 ,其所用　　立论要注意材料的翔实可靠材料存在种种疏误。

关键词：立论《经典释文》汉语语音声母归属寻文材料疏误船母切语禅母字归属两读切语两读混读百分比南朝雅音音系

缺血性卒中的一级预防——美国心脏协会/美国卒中协会卒中委员会指南动脉粥样硬化性周围血管病跨学科工作组、心血管护理委员会、临床心脏病学委员会、营养、体力活动和代谢委员会以及医疗质量和转归研究跨学科工作组共同倡导

在线全文

学校读者我要写书评

暂无评论

国际脑血管病杂志 2006年第8期14卷 572-618页

作者： Larry B. Goldstein Robert Adams Mark J. Alberts Lawrence J. Appel Lawrence M. Brass cheryl D. Bushnell Antonio culebras Thomas J. DeGraba Philip B. Gorelick John R. Guyton Robert G. Hart George Howard Margaret Kelly-Hayes J.V. (ian) Nixon Ralph L. Sacco 苏克江高宗恩解放军66393部队医院胜利油田中心医院

背景和目的本指南提供有关各种确定和潜在的卒中危险因素证据的概述,并提供降低卒中风险的推荐。方法写作组成员由委员会主席根据每位作者先前在相关课题领域中的工作提名,并经美国心脏协会(AHA)卒中委员会科学声明监督委员会批准。写... 详细信息

背景和目的本指南提供有关各种确定和潜在的卒中危险因素证据的概述,并提供降低卒中风险的推荐。方法写作组成员由委员会主席根据每位作者先前在相关课题领域中的工作提名,并经美国心脏协会(AHA)卒中委员会科学声明监督委员会批准。写作组采用系统文献回顾(涵盖时间段为2001年最后一次回顾发表到2005年1月),参考先前已发表的指南、个人文件和专家意见来概括现有的证据,指明现有知识的差距;如果合适,则根据标准的AHA标准做出简明的推荐。写作组全体成员在撰写过程中均有很多机会对推荐进行评论并认可这份声明的最终版本。在AHA科学咨询与协调委员会批准之前,本指南已进行过广泛的同行评议。结果对评价个体首次卒中风险的流程图进行评估。根据干预的可能性(不可干预、可干预或潜在可干预)和证据的强度(证据充分或证据不太充分),对首次卒中的危险因素或风险标记物进行分类。不可干预的危险因素包括年龄、性别、出生体重低、人种/种族和遗传因素。证据充分的可干预危险因素包括高血压、主动或被动吸烟、糖尿病、心房颤动和某些其他心脏病、血脂异常、颈动脉狭窄、镰状细胞病、绝经后激素治疗、不良饮食习惯、缺乏体力活动、肥胖和体脂分布。证据不太充分或潜在的可干预危险因素包括代谢综合征、酗酒、药物滥用、口服避孕药、睡眠呼吸障碍、偏头痛、高同型半胱氨酸血症、脂蛋白(a)升高、脂蛋白相关的磷脂酶升高、高凝状态、炎症和感染。对应用阿司匹林进行卒中一级预防的资料进行回顾。结论有大量证据可以用于确定增加首次卒中风险的各种特殊因素和提供降低这种风险的策略。

关键词：美国心脏协会科学声明卒中危险因素一级预防

Immunity:研究开发出最优的HIV疫苗递送模式

在线全文

学校读者我要写书评

暂无评论

现代生物医学进展 2017年第27期17卷 I0003-I0003页

作者： Matthias Pauthner colin Havenar-Daughton Devin Sok Joseph P. Nkolola Raiza Bastidas Archana V. Boopathy Diane G. carnathan Abishek chandrashekar Kimberly M. cirelli christopher A. cottrell Alexey M. Eroshkin Javier Guenaga Kirti Kaushik Daniel W. Kulp Jinyan Liu Laura E. Mccoy Aaron L. Oom Gabriel Ozorowski Kai W. Post Shailendra K. Sharma Jon M. Steichen Steven W. de Taeye Talar Tokatlian Alba Torrents de la Peña Salvatore T. Butera celia c. LaBranche David c. Montefiori Guido Silvestri ian A. Wilson Darrell J. Irvine Rogier W. Sanders William R. Schief Andrew B. Ward Richard T. Wyatt Dan H. Barouch Shane crotty Dennis R. Burton University of california San Diego La Jolla CA 92093 USA

HIV已不再占据头条新闻。这主要是因为抗逆转录病毒药物的成功开发已将HIV病毒感染导致的艾滋病（AIDS）转化为一种慢性的可控制的疾病。然而。当前在全世界大约0．367亿名HIV感染者中，仅约一半的人能够获得控制这种病毒所需的药物。... 详细信息

HIV已不再占据头条新闻。这主要是因为抗逆转录病毒药物的成功开发已将HIV病毒感染导致的艾滋病（AIDS）转化为一种慢性的可控制的疾病。然而。当前在全世界大约0．367亿名HIV感染者中，仅约一半的人能够获得控制这种病毒所需的药物。与此同时。新的HIV感染率持续保持在非常高的水平，这突出强调了需要开发一种预防性疫苗。然而，几十年来。

关键词： HIV感染者研究开发疫苗递送病毒感染逆转录病毒艾滋病感染率

Abstracts from the 15th International Myopia conference

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Eye and Vision 2016年第1期3卷 211-221页

作者： Alexandra Benavente-Perez Ann Nour Tobin Ansel Kathleen Abarr Luying Yan Keisha Roden David Troilo chanyi Lu Miaozhen Pan Min Zheng Jia Qu Xiangtian Zhou christine F. Wildsoet Fan Lu Jie chen Jinhua Bao Liang Hu Qinmei Wang Zibing Jin Frances Rucker Stephanie Britton Stephan Hanowsky Molly Spatcher Hui-Ying Kuo ching-Hsiu Ke I-Hsin Kuo chien-chun Peng Han-Yin Sun ian G. Morgan Jeremy A. Guggenheim Rupal L. Shah cathy Williams Jinglei Yang Peter S. Reinach Sen Zhang Wenfeng Sun Bo Liu Fen Li Xiaoqing Li Aihua Zhao Tianlu chen Wei Jia Jun Jiang Haoran Wu Kazuo Tsubota Hiroko Ozawa Hidemasa Torii Shigemasa Takamizawa Toshihide Kurihara Kazuno Negishi Klaus Graef Daniel Rathbun Frank Schaeffel Ladan Ghodsi William K. Stell Machelle T. Pardue Ranjay chakraborty Han na Park curran S. Sidhu P. Michael Iuvone Michael J collins Nethrajeith Srinvasalu Sally A. McFadden Paul N. Baird Pablo Artal Pauline cho SW cheung Pei-chang Wu Quan V. Hoang Duk c. Lee Erica G. Landis Michael A. Bergen curran Sidhu Samer Hattar Richard A. Stone Ravi Metlapally Ruiqin Li Qinglin Xu Hong Zhong chenglin Pan Weizhong Lan Xiaoning Li Ling chen Zhikuan Yang Scott A. Read Seang-Mei Saw Shi-Jun Weng Xiao-Hua Wu Kang-Wei Qian Yun-Yun Li Guo-Zhong Xu Furong Huang Xiong-Li Yang Yong-Mei Zhong Earl L Smith, III Baskar Arumugam Li-Fang Hung Lisa A. Ostrin Klaus Trier Monica Jong Brien A. Holden Thomas chuen Lam Samantha Shan Bing Zuo Dennis Yan-yin Tse Jingfang Bian King-Kit Li Quan Liu chi-ho To Timothy J. Gawne John T. Siegwart, Jr. Alexander H. Ward Thomas T. Norton Yan Zhang Yue Liu carol Ho Eileen Phan Abraham Hang Emily Eng christine Wildsoet Department of Biological Sciences SUNY College of Optometry New York NY 10036 USA School of Optometry and Ophthalmology and Eye Hospital Wenzhou Medical University Wenzhou Zhejiang 325027 China center for Eye Disease & Development School of Optometry & Vision Science Program University of California Berkeley Berkeley CA 94720-2020 USA Wenzhou Medical University Wenzhou Zhejiang 325027 China Biomedical Science and Disease New England College of Optom Boston MA USA School of Optometry Chung Shan Medical University Taichung City 402 Taiwan Institute of Medicine Chung Shan Medical University Taichung City 402 Taiwan Division of Biochemistry and Molecular Biology Research School of Biology Australian National University Canberra Australia State Key Laboratory of Ophthalmology and Division of Preventive Ophthalmology Zhongshan Ophthalmic Center Sun Yat-Sen University Guangzhou China School of Optometry & Vision Sciences Cardiff University Cardiff UK School of Social and community Medicine University of Bristol Bristol UK School of and Eye Hospital Wenzhou Medical University Wenzhou Zhejiang 325027 China State Key Laboratory cultivation Base and Key Laboratory of Vision Science Ministry of Health and Zhejiang Provincial Key Laboratory of Ophthalmology and Optometry Wenzhou Zhejiang 325027 People’s Republic of China Shanghai Key Laboratory of Diabetes Mellitus and center for Translational Medicine Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai 200233 China Eye Hospital of Wenzhou Medical University Wenzhou Zhejiang 325027 China Department of Ophthalmology Keio University School of Medicine Shinjuku-ku Tokyo 160-8582 Japan General Medicine Ichikawa Medical Center Urayasu City Chiba 279-0001 Japan Ophthalmic Research Institute University of Tuebingen 72076 Tuebingen Germany Bernstein center for computational Neuroscience Tuebingen 72076 Tuebingen Germany Werner Reichardt centre for Integrative Neuroscience Otfried-Mueller-Straße 25 Tueb

To assess the peripheral refractive changes that occur when eye growth decelerates in *** We measured peripheral refraction and on-axis vitreous chamber depth on a total of 53 marmosets;36 treated monocularly for 12 weeks 9 hrs/day(26 with-5 D contact lenses,10 with+5 D)and 17 untreated *** the 26 marmosets treated with-5 D,10 wore contact lenses 9 hrs/day without interruptions and were mea-sured at the end of 10 weeks of treatment(T10)and after 4 weeks of recovery(R14).Eight had both contact lenses removed for 30 mins twice/day(mid-morning and mid-afternoon)during the first four weeks of treatment(early interruption group)and eight had the lenses removed during the second four weeks of treatment(late interruption group).The two interruption groups were measured after 4,8 and 12 weeks of treatment only(T4,T8,T12).

关键词： removed treatment untreated

福建产圆斑蝰蛇(Vipera russelli siamensis)蛇毒磷酯酶A的分离纯化及部分性质研究

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Zoological Research 1981年第S1期2卷 3-8页

作者：冉永禄涂光俦王计平段志忠刘广芬王睛川陈清澄胡纫秋王锦兰武祥福中国科学院昆明动物研究所福建医科大学药理教研组中国科学院生物物理研究所中国科学院上海生物化学研究所

采用羧甲基葡聚糖c-50柱层析、葡聚糖G-75凝胶过滤和二乙氨基乙基葡聚糖A-50柱层析三步分离程序,获得了一个聚丙烯酰胺凝胶盘电泳纯的毒性磷酯酶A。用葡聚糖凝胶过滤法测得分子量为18,000,用SDS-平板聚丙烯酰胺凝胶梯度电泳法测得分子量... 详细信息

采用羧甲基葡聚糖c-50柱层析、葡聚糖G-75凝胶过滤和二乙氨基乙基葡聚糖A-50柱层析三步分离程序,获得了一个聚丙烯酰胺凝胶盘电泳纯的毒性磷酯酶A。用葡聚糖凝胶过滤法测得分子量为18,000,用SDS-平板聚丙烯酰胺凝胶梯度电泳法测得分子量为15,000,用聚丙烯酰胺凝胶等电聚焦法测得等电点为7.6。纯化的毒性磷酯酶A对昆明品系小白鼠的LD;(腹腔注射)是2微克/每克体重。磷酯酶A的比活性为24微克分子/分/毫克。纯化成分的产率是1—1.2%。

关键词：磷酯酶羧甲基葡聚糖柱层析圆斑蝰蛇聚丙烯酰胺凝胶梯度电泳比活性凝胶过滤

高效液相色谱法同时测定水源水中三种微囊藻毒素

在线全文

学校读者我要写书评

暂无评论

中国癌症防治杂志 2018年第1期10卷 24-28页

作者：肖潺潺方向梅凡彪陈茂剑曾洁吴玲红利基林黄天壬黎远冬邓伟广西医科大学附属肿瘤医院实验研究部南宁530021 广西医科大学附属肿瘤医院乳腺外科广西壮族自治区肿瘤防治研究所

目的建立一种同时测定水源水中三种微囊藻毒素(Mc-LR、Mc-RR、Mc-YR)的高效液相色谱(high performance liquid chromatography,HPLc)方法。方法取500 m L水样,0.45μm滤膜过滤,滤液过c18柱,依次用10 m L超纯水、20 m L20%甲醇溶液淋洗,1... 详细信息

目的建立一种同时测定水源水中三种微囊藻毒素(Mc-LR、Mc-RR、Mc-YR)的高效液相色谱(high performance liquid chromatography,HPLc)方法。方法取500 m L水样,0.45μm滤膜过滤,滤液过c18柱,依次用10 m L超纯水、20 m L20%甲醇溶液淋洗,15 m L 80%甲醇溶液(加入0.05%三氟乙酸)洗脱,蒸发浓缩吹干,溶于1 m L超纯水,待测。采用固相萃取柱,流动相为0.1%磷酸水溶液-乙腈(67∶33),流速1.0 m L/min,柱温45℃,在238 nm波长紫外线检测器检测。结果Mc-LR、Mc-RR和Mc-YR在0.05~1.00μg/m L范围内线性良好(r=0.9987、0.9992和0.9997),且峰形较好;回收率均在80%~110%,相对标准偏差(relative standard deviation,RSD)为5.0%~9.6%;Mc-LR、Mc-RR和Mc-YR的方法检出限(limit of detection,LOD)分别为0.028μg/L、0.037μg/L和0.056μg/L。结论本方法准确度、灵敏度、回收率高,重现性好,可用于水源水中Mc-LR、Mc-RR、Mc-YR同时检测。

关键词：水源水微囊藻毒素高效液相色谱水体富营养化

联合应用血清肿瘤标记物cA125和SM R对卵巢癌诊断及早期检测的意义

在线全文

学校读者我要写书评

暂无评论

世界核心医学期刊文摘（妇产科学分册） 2005年第2期1卷 43-43页

作者： McIntosh M.W. Drescher c. Karlan B. 张剑萍

The serum tumor marker cA 125is elevated in most clin-ically advanced ovarian *** these eleva-tions may precede clinical detectio n by a year or more,cA125is potentially useful for early d etection as part of an ovarian cancer screening program.H owever,cA 125is often not elevated in clinically detected cancer and is fre-quently elevated in women with benig n ovarian ***125may be more useful in conjunction with one or more other tumor *** could play a role if,when usedwith cA 125,they id entify some carci-nomas missed by cA 125(i.e.,they improve sensitivity),rule out false positives(i.e.,improve specificity),or are able to detect the same cancers earli *** have evaluated a composite marker(cM)that combines cA 125and a previously described soluble mesothelin related(SMR)marker in sera from 52ovarian cancer cases,43controls with benign ovarian tumors,and 220n ormal risk controls who participated in a screening program,including 25healthywomen having two serum sampl es collected 1year *** 125,SMR,and cM were evaluated for their ability to identify clinical disease and for their temporal stability,which assesses their abi lity to obtain even greater sensitivity when used in a longitudi nal screening *** has the best sensitivity,with specificity equal to ***,cM has temporal stability at least as high as cA *** cM may outperform c A 125alone in a longitudinal screening program as well as in a diagnostic setting.

关键词：卵巢癌诊断 SM R 血清肿瘤标记物早期检测良性卵巢肿瘤晚期卵巢癌早期卵巢癌早期筛查阳性病例筛查方案

每日与每周局部应用5%氟尿嘧啶(Efudix~霜)治疗光化性角化病的随机试验

在线全文

学校读者我要写书评

暂无评论

世界核心医学期刊文摘（皮肤病学分册） 2006年第1期2卷 41-41页

作者： Jury c.S Ramraka-Jones V.S Gudi V Herd R.M 罗素菊 Department of Dermatology Western Infirmary North Glasgow Hospitals University Glasgow United Kingdom

Background: Topical 5-fluorouracil (5-FU) cream is widely used in the treatment of actinic keratoses (AKs) but the optimumtreatment regimen that provides efficacywhileminimizing side-effects remains unclear. Objectives A randomized trial to compare the efficacy and side-effects of daily vs. weekly application of 5%5-FU in the treatment of AKs of the scalp and face. Patients/methods Twenty patients were recruited and randomized to two groups. Group 1 (13 patients) appl ied 5%5-FU twice daily for 3 weeks, group 2 (seven patients) applied 5%5-FU twice daily for 1 day per week for 12 weeks. Patients were reviewed at weeks 3, 12, 24 and 52. At each review a lesion count and lesion map were completed and p atients were asked to score efficacy and inflammation. Results At week 0 the med ian lesion count was the same in both groups, 17.5 lesions. At 12 weeks the medi an lesion count in group 1 had fallen to 0 where it remained for the duration of follow-up. In group 2 the median lesion count fell to 6 at 12 weeks, 5.5 at 24 weeks and was 3 at 52 weeks. The difference in the lesion count was significant at all time points after week 0: P core was higher in patients clear of AKs at 12 we eks compared with those who had not cleared, 3.8 compared with 1.9. This differe nce was statistically significant (P c essary for efficacy. conclusions We conclude that daily application of 5%5-FU cream is more effective than weekly application at clearing AKs from the scalp a nd face. Our results also suggest that inflammation is likely to be required to achieve a therapeutic effect.

关键词：光化性角化病 Efudix 尿嘧啶局部应用随机试验最佳治疗方法皮损数目炎症反应中位值评

一个基于深度学习的眼病和肺炎两大类疾病的AI诊断系统

在线全文

学校读者我要写书评

暂无评论

科学新闻 2019年第2期 33-33页

作者： Daniel S.Kermany Michael Goldbaum Wenjia cai carolina c.S.Valentim Huiying Liang Sally L.Baxter Alex McKeown Ge Yang Xiaokang Wu Fangbing Yan Justin Dong Made K.Prasadha Jacqueline Pei Magdalene Y.L.Ting Jie Zhu christina Li Sierra Hewett Jason Dong ian Ziyar Alexander Shi Runze Zhang Rui Hou William Shi Xin Fu Yaou Duan Viet A.N. Huu cindy Wen Edward D. Zhang charlotte L. Zhang Oulan Li Xiaobo Wang Michael A. Singer Xiaodong Sun Jie Xu Ali Tafreshi M. Anthony Lewis Huimin Xia 张康美国加州大学圣地亚哥分校人类基因组医学研究所

文章简介本研究开发了一个基于深度学习框架能诊断致盲性视网膜疾病的人工智能(AI)诊断工具。而且,该AI诊断工具还可用于诊断小儿肺炎。这是一项将AI应用于医疗领域的重磅研究成果,有望高精确诊断多种可治疗性疾病。在眼科治疗中,视网膜... 详细信息

文章简介本研究开发了一个基于深度学习框架能诊断致盲性视网膜疾病的人工智能(AI)诊断工具。而且,该AI诊断工具还可用于诊断小儿肺炎。这是一项将AI应用于医疗领域的重磅研究成果,有望高精确诊断多种可治疗性疾病。在眼科治疗中,视网膜OcT(光学相干断层扫描)

关键词： AI 深度学习

Observatory science with eXTP

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

Science china(Physics,Mechanics & Astronomy) 2019年第2期62卷 97-138页

作者： Jean J.M.in 't Zand Enrico Bozzo JinLu Qu Xiang-Dong Li Lorenzo Amati Yang chen Immacolata Donnarumma Victor Doroshenko Stephen A.Drake Margarita Hernanz Peter A.Jenke Thomas J.Maccarone Simin Mahmoodifar Domitilla de Martino Alessandra De Rosa Elena M.Rossi Antonia Rowlinson Gloria Sala Giulia Stratta Thomas M.Tauris Joern Wilms XueFeng Wu Ping Zhou Iván Agudo Diego Altamirano Jean-Luc Atteia Nils A.andersson M.cristina Baglio David R.Ballantyne Altan Baykal Ehud Behar Tomaso Belloni Sudip Bhattacharyya Stefano Bianchi Anna Bilous Pere Blay Joao Braga Sφren Brandt Edward F.Brown Niccolo Bucciantini Luciano Burderi Edward M.cackett Riccardo campana Sergio campana Piergiorgio casella Yuri cavecchi Frank chambers Liang chen Yu-Peng chen Jér?me chenevez Maria chernyakova chichuan Jin Riccardo ciolfi Elisa costantini Andrew cumming Antonino D'Aì Zi-Gao Dai Filippo D'Ammando Massimiliano De Pasquale Nathalie Degenaar Melania Del Santo Valerio D'Elia Tiziana Di Salvo Gerry Doyle Maurizio Falanga XiLong Fan Robert D.Ferdman Marco Feroci Federico Fraschetti Duncan K.Galloway Angelo F.Gambino Poshak Gandhi MingYu Ge Bruce Gendre Ramandeep Gill Diego G?tz christian Gouiffès Paola Grandi Jonathan Granot Manuel Güdel Alexander Heger craig O.Heinke Jeroen Homan Rosario Iaria Kazushi Iwasawa Luca Izzo Long Ji Peter G.Jonker Jordi José Jelle S.Kaastra Emrah Kalemci Oleg Kargaltsev Nobuyuki Kawai Laurens Keek Stefanie Komossa Ingo Kreykenbohm Lucien Kuiper Devaky Kunneriath Gang Li En-Wei Liang Manuel Linares Francesco Longo FangJun Lu Alexander A.Lutovinov Denys Malyshev Julien Malzac Antonios Manousakis ian McHardy Missagh Mehdipour YunPeng Men Mariano Méndez Roberto P.Mignani Romana Mikusincova M.coleman Miller Giovanni Miniutti christian Motch Joonas Nättilä Emanuele Nardini Torsten Neubert Paul T.O'Brien Mauro Orlandini Julian P.Osborne Luigi Pacciani Stéphane Paltani Maurizio Paolillo Iossif E.Papadakis Biswajit Paul Alberto Pellizzoni Uria Peretz Miguel A.Pérez Torres Emanuele Perinati chanda Prescod-Weinstein Pablo Reig SRON Netherlands Institute for Space Research Department of Astronomy University of Geneva Key Laboratory for Particle Astrophysics Institute of High Energy PhysicsChinese Academy of Sciences School of Astronomy and Space Science Nanjing University INAF-IASF Bologna ASI Via del Politecnico snc INAF-Istituto di Astrofisica e Planetologie Spaziali Institut für Astronomie und Astrophysik Tübingen Universit?t Tübingen NASA Goddard Space Flight center IcREA&Institute of Space Sciences(IEEc-cSIc) Campus UABCarrer de Can Magrans cSPAR SPA University of Alabama in Huntsville Department of Physics Texas Tech University INAF Osservatorio Astronomico di capodimonte Leiden Observatory Leiden University Anton Pannekoek Institute University of Amsterdam ASTRON Netherlands Institute for Radio Astronomy Universitat Politecnica de catalunya(UPc-IEEc) Universitádegli Studi di Urbino‘carlo Bo’ Max-Planck-Institut für Radioastronomie Dr.Karl-Remeis-Sternwarte and Erlangen centre for Astroparticle Physics(EcAP) Friedrich Alexander Universit?t Erlangen-Nurnberg Purple Mountain Observatory Chinese Academy of Sciences Instituto de Astrofysíca de Andalucia-cSIc Department of Physics and Astronomy University of Southampton IRAP Universitéde ToulouseCNRSUPSCNES Mathematical Sciences and STAG Research centre University of Southampton New York University Abu Dhabi center for Relativistic Astrophysics School of PhysicsGeorgia Institute of Technology Physics Department Middle East Technical University Department of Physics Technion-Israel Institute of Technology INAF Osservatorio Astronomico di Brera Tata Institute of Fundamental Research Dipartimento di Matematica e Fisica Universitàdegli Studi Roma Tre Instituto de Astrofísica de canarias Instituto Nacional de Pesquisas Espaciais-INPE National Space Institute Technical University of Denmark(DTU Space) Department of Physics and Astronomy Michigan State University INAF Osservatorio Astrofisico di Arcetri Dipartimento di Fisica Universitádegli Studi di Cagliari Department of Physics and A

In this White Paper we present the potential of the enhanced X-ray Timing and Polarimetry(eXTP) mission for studies related to Observatory Science targets. These include flaring stars, supernova remnants, accreting white dwarfs, low and high mass X-ray binaries, radio quiet and radio loud active galactic nuclei, tidal disruption events, and gamma-ray bursts. eXTP will be excellently suited to study one common aspect of these objects: their often transient nature. Developed by an international consortium led by the Institute of High Energy Physics of the chinese Academy of Science, the eXTP mission is expected to be launched in the mid 2020s.

关键词： space research in struments nuclear astrophysics flare stars accretion and accretion disks mass loss and stellar winds cataclysmic binaries X-ray binaries supernova remnants active galactic nuclei X-ray bursts gamma-ray bursts gravitational waves